Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer.

Cancers (Basel) · 2021 · PMC8037571 · PMID 33916221

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Though not statistically significant for this small population, the survival analysis showed a trend towards an improved OS for CCOC, suggesting that immunotherapy should be further investigated in this setting.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.